id	sid	tid	token	lemma	pos
dpc-1656	1	1	dermatology	dermatology	NOUN
dpc-1656	1	2	:	:	PUNCT
dpc-1656	1	3	practical	practical	ADJ
dpc-1656	1	4	and	and	CCONJ
dpc-1656	1	5	conceptual	conceptual	ADJ
dpc-1656	1	6	dermatology	dermatology	NOUN
dpc-1656	1	7	practical	practical	ADJ
dpc-1656	1	8	&	&	CCONJ
dpc-1656	1	9	conceptual	conceptual	ADJ
dpc-1656	1	10	research	research	NOUN
dpc-1656	1	11	letter	letter	NOUN
dpc-1656	2	1	|	|	ADV
dpc-1656	2	2	dermatol	dermatol	ADJ
dpc-1656	2	3	pract	pract	NOUN
dpc-1656	2	4	concept	concept	NOUN
dpc-1656	2	5	.	.	PUNCT
dpc-1656	3	1	2022;12(1):e2022005	2022;12(1):e2022005	NUM
dpc-1656	3	2	1	1	NUM
dpc-1656	3	3	diffuse	diffuse	VERB
dpc-1656	3	4	juvenile	juvenile	ADJ
dpc-1656	3	5	bullous	bullous	ADJ
dpc-1656	3	6	pemphigoid	pemphigoid	NOUN
dpc-1656	3	7	managed	manage	VERB
dpc-1656	3	8	successfully	successfully	ADV
dpc-1656	3	9	with	with	ADP
dpc-1656	3	10	a	a	DET
dpc-1656	3	11	short	short	ADJ
dpc-1656	3	12	course	course	NOUN
dpc-1656	3	13	of	of	ADP
dpc-1656	3	14	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	3	15	seema	seema	PROPN
dpc-1656	3	16	rani1	rani1	PROPN
dpc-1656	3	17	,	,	PUNCT
dpc-1656	3	18	diksha	diksha	PROPN
dpc-1656	3	19	aggarwal1	aggarwal1	PROPN
dpc-1656	3	20	,	,	PUNCT
dpc-1656	3	21	kabir	kabir	PROPN
dpc-1656	3	22	sardana1	sardana1	PROPN
dpc-1656	3	23	,	,	PUNCT
dpc-1656	3	24	savitha	savitha	PROPN
dpc-1656	3	25	bathula1	bathula1	PROPN
dpc-1656	3	26	,	,	PUNCT
dpc-1656	3	27	purnima	purnima	PROPN
dpc-1656	3	28	malhotra2	malhotra2	PROPN
dpc-1656	3	29	1	1	NUM
dpc-1656	3	30	department	department	NOUN
dpc-1656	3	31	of	of	ADP
dpc-1656	3	32	dermatology	dermatology	NOUN
dpc-1656	3	33	,	,	PUNCT
dpc-1656	3	34	atal	atal	PROPN
dpc-1656	3	35	bihari	bihari	PROPN
dpc-1656	3	36	vajpayee	vajpayee	PROPN
dpc-1656	3	37	institute	institute	PROPN
dpc-1656	3	38	of	of	ADP
dpc-1656	3	39	medical	medical	PROPN
dpc-1656	3	40	sciences	sciences	PROPN
dpc-1656	3	41	(	(	PUNCT
dpc-1656	3	42	abvims	abvim	NOUN
dpc-1656	3	43	)	)	PUNCT
dpc-1656	3	44	and	and	CCONJ
dpc-1656	3	45	dr	dr	PROPN
dpc-1656	3	46	.	.	PROPN
dpc-1656	3	47	ram	ram	PROPN
dpc-1656	3	48	manohar	manohar	PROPN
dpc-1656	3	49	lohia	lohia	PROPN
dpc-1656	3	50	hospital	hospital	PROPN
dpc-1656	3	51	,	,	PUNCT
dpc-1656	3	52	new	new	PROPN
dpc-1656	3	53	delhi	delhi	PROPN
dpc-1656	3	54	,	,	PUNCT
dpc-1656	3	55	india	india	PROPN
dpc-1656	3	56	2	2	NUM
dpc-1656	3	57	department	department	NOUN
dpc-1656	3	58	of	of	ADP
dpc-1656	3	59	pathology	pathology	PROPN
dpc-1656	3	60	,	,	PUNCT
dpc-1656	3	61	atal	atal	PROPN
dpc-1656	3	62	bihari	bihari	PROPN
dpc-1656	3	63	vajpayee	vajpayee	PROPN
dpc-1656	3	64	institute	institute	PROPN
dpc-1656	3	65	of	of	ADP
dpc-1656	3	66	medical	medical	PROPN
dpc-1656	3	67	sciences	sciences	PROPN
dpc-1656	3	68	(	(	PUNCT
dpc-1656	3	69	abvims	abvim	NOUN
dpc-1656	3	70	)	)	PUNCT
dpc-1656	3	71	and	and	CCONJ
dpc-1656	3	72	dr	dr	PROPN
dpc-1656	3	73	.	.	PROPN
dpc-1656	3	74	ram	ram	PROPN
dpc-1656	3	75	manohar	manohar	PROPN
dpc-1656	3	76	lohia	lohia	PROPN
dpc-1656	3	77	hospital	hospital	PROPN
dpc-1656	3	78	,	,	PUNCT
dpc-1656	3	79	new	new	PROPN
dpc-1656	3	80	delhi	delhi	PROPN
dpc-1656	3	81	,	,	PUNCT
dpc-1656	3	82	india	india	PROPN
dpc-1656	3	83	key	key	ADJ
dpc-1656	3	84	words	word	NOUN
dpc-1656	3	85	:	:	PUNCT
dpc-1656	3	86	immunobullous	immunobullous	ADJ
dpc-1656	3	87	,	,	PUNCT
dpc-1656	3	88	bullous	bullous	ADJ
dpc-1656	3	89	pemphigoid	pemphigoid	NOUN
dpc-1656	3	90	,	,	PUNCT
dpc-1656	3	91	cyclophosphamide	cyclophosphamide	NOUN
dpc-1656	3	92	,	,	PUNCT
dpc-1656	3	93	juvenile	juvenile	VERB
dpc-1656	3	94	bullous	bullous	ADJ
dpc-1656	3	95	pemphigoid	pemphigoid	ADJ
dpc-1656	3	96	citation	citation	NOUN
dpc-1656	3	97	:	:	PUNCT
dpc-1656	3	98	rani	rani	PROPN
dpc-1656	3	99	s	s	PROPN
dpc-1656	3	100	,	,	PUNCT
dpc-1656	3	101	aggarwal	aggarwal	PROPN
dpc-1656	3	102	d	d	PROPN
dpc-1656	3	103	,	,	PUNCT
dpc-1656	3	104	sardana	sardana	PROPN
dpc-1656	3	105	k	k	PROPN
dpc-1656	3	106	,	,	PUNCT
dpc-1656	3	107	savitha	savitha	PROPN
dpc-1656	3	108	b	b	PROPN
dpc-1656	3	109	,	,	PUNCT
dpc-1656	3	110	malhotra	malhotra	PROPN
dpc-1656	3	111	p.	p.	PROPN
dpc-1656	3	112	diffuse	diffuse	PROPN
dpc-1656	3	113	juvenile	juvenile	ADJ
dpc-1656	3	114	bullous	bullous	ADJ
dpc-1656	3	115	pemphigoid	pemphigoid	NOUN
dpc-1656	3	116	managed	manage	VERB
dpc-1656	3	117	successfully	successfully	ADV
dpc-1656	3	118	with	with	ADP
dpc-1656	3	119	a	a	DET
dpc-1656	3	120	short	short	ADJ
dpc-1656	3	121	course	course	NOUN
dpc-1656	3	122	of	of	ADP
dpc-1656	3	123	cyclophosphamide	cyclophosphamide	NOUN
dpc-1656	3	124	.	.	PUNCT
dpc-1656	4	1	dermatol	dermatol	NOUN
dpc-1656	4	2	pract	pract	PROPN
dpc-1656	4	3	concept	concept	NOUN
dpc-1656	4	4	.	.	PUNCT
dpc-1656	5	1	2022;12(1):e2022005	2022;12(1):e2022005	X
dpc-1656	5	2	.	.	PUNCT
dpc-1656	5	3	doi	doi	PROPN
dpc-1656	5	4	:	:	PUNCT
dpc-1656	5	5	https://doi.org/10.5826/dpc.1201a05	https://doi.org/10.5826/dpc.1201a05	ADJ
dpc-1656	5	6	accepted	accept	VERB
dpc-1656	5	7	:	:	PUNCT
dpc-1656	5	8	april	april	PROPN
dpc-1656	5	9	18	18	NUM
dpc-1656	5	10	,	,	PUNCT
dpc-1656	5	11	2021	2021	NUM
dpc-1656	5	12	;	;	PUNCT
dpc-1656	5	13	published	publish	VERB
dpc-1656	5	14	:	:	PUNCT
dpc-1656	5	15	january	january	PROPN
dpc-1656	5	16	2022	2022	NUM
dpc-1656	6	1	copyright	copyright	NOUN
dpc-1656	6	2	:	:	PUNCT
dpc-1656	6	3	©	©	PROPN
dpc-1656	6	4	2022	2022	NUM
dpc-1656	6	5	rani	rani	NOUN
dpc-1656	6	6	et	et	PROPN
dpc-1656	6	7	al	al	PROPN
dpc-1656	6	8	.	.	PUNCT
dpc-1656	7	1	this	this	PRON
dpc-1656	7	2	is	be	AUX
dpc-1656	7	3	an	an	DET
dpc-1656	7	4	open	open	ADJ
dpc-1656	7	5	-	-	PUNCT
dpc-1656	7	6	access	access	NOUN
dpc-1656	7	7	article	article	NOUN
dpc-1656	7	8	distributed	distribute	VERB
dpc-1656	7	9	under	under	ADP
dpc-1656	7	10	the	the	DET
dpc-1656	7	11	terms	term	NOUN
dpc-1656	7	12	of	of	ADP
dpc-1656	7	13	the	the	DET
dpc-1656	7	14	creative	creative	ADJ
dpc-1656	7	15	commons	common	NOUN
dpc-1656	7	16	attribution	attribution	NOUN
dpc-1656	7	17	-	-	PUNCT
dpc-1656	7	18	noncommercial	noncommercial	ADJ
dpc-1656	7	19	license	license	NOUN
dpc-1656	7	20	(	(	PUNCT
dpc-1656	7	21	by	by	ADP
dpc-1656	7	22	-	-	PUNCT
dpc-1656	7	23	nc-4.0	nc-4.0	NOUN
dpc-1656	7	24	)	)	PUNCT
dpc-1656	7	25	,	,	PUNCT
dpc-1656	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1656	7	27	,	,	PUNCT
dpc-1656	7	28	which	which	PRON
dpc-1656	7	29	permits	permit	VERB
dpc-1656	7	30	unrestricted	unrestricted	ADJ
dpc-1656	7	31	noncommercial	noncommercial	ADJ
dpc-1656	7	32	use	use	NOUN
dpc-1656	7	33	,	,	PUNCT
dpc-1656	7	34	distribution	distribution	NOUN
dpc-1656	7	35	,	,	PUNCT
dpc-1656	7	36	and	and	CCONJ
dpc-1656	7	37	reproduction	reproduction	NOUN
dpc-1656	7	38	in	in	ADP
dpc-1656	7	39	any	any	DET
dpc-1656	7	40	medium	medium	NOUN
dpc-1656	7	41	,	,	PUNCT
dpc-1656	7	42	provided	provide	VERB
dpc-1656	7	43	the	the	DET
dpc-1656	7	44	original	original	ADJ
dpc-1656	7	45	authors	author	NOUN
dpc-1656	7	46	and	and	CCONJ
dpc-1656	7	47	source	source	NOUN
dpc-1656	7	48	are	be	AUX
dpc-1656	7	49	credited	credit	VERB
dpc-1656	7	50	.	.	PUNCT
dpc-1656	8	1	funding	funding	NOUN
dpc-1656	8	2	:	:	PUNCT
dpc-1656	8	3	none	none	NOUN
dpc-1656	8	4	.	.	PUNCT
dpc-1656	9	1	competing	compete	VERB
dpc-1656	9	2	interests	interest	NOUN
dpc-1656	9	3	:	:	PUNCT
dpc-1656	9	4	none	none	NOUN
dpc-1656	9	5	.	.	PUNCT
dpc-1656	10	1	authorship	authorship	NOUN
dpc-1656	10	2	:	:	PUNCT
dpc-1656	10	3	all	all	DET
dpc-1656	10	4	authors	author	NOUN
dpc-1656	10	5	have	have	AUX
dpc-1656	10	6	contributed	contribute	VERB
dpc-1656	10	7	significantly	significantly	ADV
dpc-1656	10	8	to	to	ADP
dpc-1656	10	9	this	this	DET
dpc-1656	10	10	publication	publication	NOUN
dpc-1656	10	11	.	.	PUNCT
dpc-1656	11	1	corresponding	correspond	VERB
dpc-1656	11	2	author	author	NOUN
dpc-1656	11	3	:	:	PUNCT
dpc-1656	11	4	seema	seema	PROPN
dpc-1656	11	5	rani	rani	PROPN
dpc-1656	11	6	,	,	PUNCT
dpc-1656	11	7	associate	associate	NOUN
dpc-1656	11	8	professor	professor	NOUN
dpc-1656	11	9	,	,	PUNCT
dpc-1656	11	10	department	department	NOUN
dpc-1656	11	11	of	of	ADP
dpc-1656	11	12	dermatology	dermatology	NOUN
dpc-1656	11	13	,	,	PUNCT
dpc-1656	11	14	atal	atal	PROPN
dpc-1656	11	15	bihari	bihari	PROPN
dpc-1656	11	16	vajpayee	vajpayee	PROPN
dpc-1656	11	17	institute	institute	PROPN
dpc-1656	11	18	of	of	ADP
dpc-1656	11	19	medical	medical	PROPN
dpc-1656	11	20	sciences	sciences	PROPN
dpc-1656	11	21	(	(	PUNCT
dpc-1656	11	22	abvims	abvim	NOUN
dpc-1656	11	23	)	)	PUNCT
dpc-1656	11	24	and	and	CCONJ
dpc-1656	11	25	dr	dr	PROPN
dpc-1656	11	26	.	.	PROPN
dpc-1656	11	27	ram	ram	PROPN
dpc-1656	11	28	manohar	manohar	PROPN
dpc-1656	11	29	lohia	lohia	PROPN
dpc-1656	11	30	hospital	hospital	PROPN
dpc-1656	11	31	,	,	PUNCT
dpc-1656	11	32	new	new	PROPN
dpc-1656	11	33	delhi	delhi	PROPN
dpc-1656	11	34	,	,	PUNCT
dpc-1656	11	35	india	india	PROPN
dpc-1656	11	36	.	.	PUNCT
dpc-1656	12	1	e	e	X
dpc-1656	12	2	-	-	NOUN
dpc-1656	12	3	mail	mail	NOUN
dpc-1656	12	4	:	:	PUNCT
dpc-1656	13	1	drseemashekhar@gmail.com	drseemashekhar@gmail.com	X
dpc-1656	13	2	introduction	introduction	NOUN
dpc-1656	13	3	adolescent	adolescent	ADJ
dpc-1656	13	4	bullous	bullous	ADJ
dpc-1656	13	5	pemphigoid	pemphigoid	NOUN
dpc-1656	13	6	(	(	PUNCT
dpc-1656	13	7	bp	bp	PROPN
dpc-1656	13	8	)	)	PUNCT
dpc-1656	13	9	is	be	AUX
dpc-1656	13	10	a	a	DET
dpc-1656	13	11	very	very	ADV
dpc-1656	13	12	rare	rare	ADJ
dpc-1656	13	13	entity	entity	NOUN
dpc-1656	13	14	—	—	PUNCT
dpc-1656	13	15	with	with	ADP
dpc-1656	13	16	generalized	generalized	ADJ
dpc-1656	13	17	(	(	PUNCT
dpc-1656	13	18	erythrodermic	erythrodermic	ADJ
dpc-1656	13	19	)	)	PUNCT
dpc-1656	13	20	variant	variant	NOUN
dpc-1656	13	21	being	be	AUX
dpc-1656	13	22	even	even	ADV
dpc-1656	13	23	rarer	rarer	ADV
dpc-1656	13	24	—	—	PUNCT
dpc-1656	13	25	and	and	CCONJ
dpc-1656	13	26	management	management	NOUN
dpc-1656	13	27	of	of	ADP
dpc-1656	13	28	such	such	ADJ
dpc-1656	13	29	difficult	difficult	ADJ
dpc-1656	13	30	bp	bp	NOUN
dpc-1656	13	31	cases	case	NOUN
dpc-1656	13	32	can	can	AUX
dpc-1656	13	33	be	be	AUX
dpc-1656	13	34	challenging	challenge	VERB
dpc-1656	13	35	.	.	PUNCT
dpc-1656	14	1	case	case	NOUN
dpc-1656	14	2	presentation	presentation	NOUN
dpc-1656	14	3	a	a	DET
dpc-1656	14	4	17	17	NUM
dpc-1656	14	5	-	-	PUNCT
dpc-1656	14	6	year	year	NOUN
dpc-1656	14	7	-	-	PUNCT
dpc-1656	14	8	old	old	ADJ
dpc-1656	14	9	girl	girl	NOUN
dpc-1656	14	10	presented	present	VERB
dpc-1656	14	11	with	with	ADP
dpc-1656	14	12	a	a	DET
dpc-1656	14	13	1	1	NUM
dpc-1656	14	14	-	-	PUNCT
dpc-1656	14	15	month	month	NOUN
dpc-1656	14	16	history	history	NOUN
dpc-1656	14	17	of	of	ADP
dpc-1656	14	18	intense	intense	ADJ
dpc-1656	14	19	pruritus	pruritus	NOUN
dpc-1656	14	20	that	that	PRON
dpc-1656	14	21	was	be	AUX
dpc-1656	14	22	followed	follow	VERB
dpc-1656	14	23	by	by	ADP
dpc-1656	14	24	the	the	DET
dpc-1656	14	25	development	development	NOUN
dpc-1656	14	26	of	of	ADP
dpc-1656	14	27	multiple	multiple	ADJ
dpc-1656	14	28	fluid	fluid	NOUN
dpc-1656	14	29	-	-	PUNCT
dpc-1656	14	30	filled	fill	VERB
dpc-1656	14	31	lesions	lesion	NOUN
dpc-1656	14	32	.	.	PUNCT
dpc-1656	15	1	these	these	DET
dpc-1656	15	2	lesions	lesion	NOUN
dpc-1656	15	3	ruptured	rupture	VERB
dpc-1656	15	4	spontaneously	spontaneously	ADV
dpc-1656	15	5	in	in	ADP
dpc-1656	15	6	3	3	NUM
dpc-1656	15	7	to	to	PART
dpc-1656	15	8	4	4	NUM
dpc-1656	15	9	days	day	NOUN
dpc-1656	15	10	and	and	CCONJ
dpc-1656	15	11	left	leave	VERB
dpc-1656	15	12	behind	behind	ADP
dpc-1656	15	13	painful	painful	ADJ
dpc-1656	15	14	erosions	erosion	NOUN
dpc-1656	15	15	.	.	PUNCT
dpc-1656	16	1	there	there	PRON
dpc-1656	16	2	was	be	VERB
dpc-1656	16	3	no	no	DET
dpc-1656	16	4	history	history	NOUN
dpc-1656	16	5	of	of	ADP
dpc-1656	16	6	drug	drug	NOUN
dpc-1656	16	7	intake	intake	NOUN
dpc-1656	16	8	,	,	PUNCT
dpc-1656	16	9	trauma	trauma	NOUN
dpc-1656	16	10	,	,	PUNCT
dpc-1656	16	11	recent	recent	ADJ
dpc-1656	16	12	vaccination	vaccination	NOUN
dpc-1656	16	13	,	,	PUNCT
dpc-1656	16	14	fever	fever	NOUN
dpc-1656	16	15	,	,	PUNCT
dpc-1656	16	16	or	or	CCONJ
dpc-1656	16	17	photosensitivity	photosensitivity	NOUN
dpc-1656	16	18	.	.	PUNCT
dpc-1656	17	1	notably	notably	ADV
dpc-1656	17	2	,	,	PUNCT
dpc-1656	17	3	she	she	PRON
dpc-1656	17	4	had	have	VERB
dpc-1656	17	5	an	an	DET
dpc-1656	17	6	intellectual	intellectual	ADJ
dpc-1656	17	7	disability	disability	NOUN
dpc-1656	17	8	;	;	PUNCT
dpc-1656	17	9	however	however	ADV
dpc-1656	17	10	,	,	PUNCT
dpc-1656	17	11	the	the	DET
dpc-1656	17	12	psychiatric	psychiatric	ADJ
dpc-1656	17	13	consultation	consultation	NOUN
dpc-1656	17	14	was	be	AUX
dpc-1656	17	15	normal	normal	ADJ
dpc-1656	17	16	.	.	PUNCT
dpc-1656	18	1	cutaneous	cutaneous	ADJ
dpc-1656	18	2	examination	examination	NOUN
dpc-1656	18	3	revealed	reveal	VERB
dpc-1656	18	4	multiple	multiple	ADJ
dpc-1656	18	5	tensevesicles	tensevesicle	NOUN
dpc-1656	18	6	,	,	PUNCT
dpc-1656	18	7	both	both	CCONJ
dpc-1656	18	8	clear	clear	ADJ
dpc-1656	18	9	and	and	CCONJ
dpc-1656	18	10	hemorrhagic	hemorrhagic	NOUN
dpc-1656	18	11	,	,	PUNCT
dpc-1656	18	12	and	and	CCONJ
dpc-1656	18	13	bullae	bullae	VERB
dpc-1656	18	14	over	over	ADP
dpc-1656	18	15	an	an	DET
dpc-1656	18	16	erythematous	erythematous	ADJ
dpc-1656	18	17	base	base	NOUN
dpc-1656	18	18	that	that	PRON
dpc-1656	18	19	involved	involve	VERB
dpc-1656	18	20	90	90	NUM
dpc-1656	18	21	%	%	NOUN
dpc-1656	18	22	of	of	ADP
dpc-1656	18	23	the	the	DET
dpc-1656	18	24	body	body	NOUN
dpc-1656	18	25	surface	surface	NOUN
dpc-1656	18	26	areaalong	areaalong	ADJ
dpc-1656	18	27	with	with	ADP
dpc-1656	18	28	involvement	involvement	NOUN
dpc-1656	18	29	of	of	ADP
dpc-1656	18	30	head	head	NOUN
dpc-1656	18	31	and	and	CCONJ
dpc-1656	18	32	neck	neck	NOUN
dpc-1656	18	33	areas	area	NOUN
dpc-1656	18	34	(	(	PUNCT
dpc-1656	18	35	figure1a	figure1a	NOUN
dpc-1656	18	36	)	)	PUNCT
dpc-1656	18	37	.	.	PUNCT
dpc-1656	19	1	nails	nail	NOUN
dpc-1656	19	2	and	and	CCONJ
dpc-1656	19	3	mucosa	mucosa	NOUN
dpc-1656	19	4	were	be	AUX
dpc-1656	19	5	unaffected	unaffected	ADJ
dpc-1656	19	6	.	.	PUNCT
dpc-1656	20	1	bulla	bulla	PROPN
dpc-1656	20	2	spread	spread	NOUN
dpc-1656	20	3	sign	sign	NOUN
dpc-1656	20	4	was	be	AUX
dpc-1656	20	5	positive	positive	ADJ
dpc-1656	20	6	and	and	CCONJ
dpc-1656	20	7	nikolsky	nikolsky	ADJ
dpc-1656	20	8	sign	sign	NOUN
dpc-1656	20	9	was	be	AUX
dpc-1656	20	10	negative	negative	ADJ
dpc-1656	20	11	.	.	PUNCT
dpc-1656	21	1	tzanck	tzanck	ADJ
dpc-1656	21	2	smear	smear	NOUN
dpc-1656	21	3	showed	show	VERB
dpc-1656	21	4	eosinophils	eosinophil	NOUN
dpc-1656	21	5	and	and	CCONJ
dpc-1656	21	6	neutrophils	neutrophil	NOUN
dpc-1656	21	7	.	.	PUNCT
dpc-1656	22	1	the	the	DET
dpc-1656	22	2	total	total	ADJ
dpc-1656	22	3	leukocyte	leukocyte	NOUN
dpc-1656	22	4	count	count	NOUN
dpc-1656	22	5	was	be	AUX
dpc-1656	22	6	20,000	20,000	NUM
dpc-1656	22	7	per	per	ADP
dpc-1656	22	8	mm3	mm3	NOUN
dpc-1656	22	9	with	with	ADP
dpc-1656	22	10	77	77	NUM
dpc-1656	22	11	%	%	NOUN
dpc-1656	22	12	eosinophils	eosinophil	NOUN
dpc-1656	22	13	in	in	ADP
dpc-1656	22	14	differential	differential	ADJ
dpc-1656	22	15	leukocyte	leukocyte	NOUN
dpc-1656	22	16	count	count	NOUN
dpc-1656	22	17	and	and	CCONJ
dpc-1656	22	18	an	an	DET
dpc-1656	22	19	absolute	absolute	ADJ
dpc-1656	22	20	eosinophil	eosinophil	ADJ
dpc-1656	22	21	count	count	NOUN
dpc-1656	22	22	of	of	ADP
dpc-1656	22	23	15,400	15,400	NUM
dpc-1656	22	24	per	per	ADP
dpc-1656	22	25	mm3	mm3	PROPN
dpc-1656	22	26	.	.	PUNCT
dpc-1656	23	1	the	the	DET
dpc-1656	23	2	serum	serum	PROPN
dpc-1656	23	3	immunoglobulin	immunoglobulin	PROPN
dpc-1656	23	4	(	(	PUNCT
dpc-1656	23	5	ig	ig	PROPN
dpc-1656	23	6	)	)	PUNCT
dpc-1656	23	7	e	e	NOUN
dpc-1656	23	8	level	level	NOUN
dpc-1656	23	9	was	be	AUX
dpc-1656	23	10	normal	normal	ADJ
dpc-1656	23	11	.	.	PUNCT
dpc-1656	24	1	histopathology	histopathology	NOUN
dpc-1656	24	2	revealed	reveal	VERB
dpc-1656	24	3	focal	focal	ADJ
dpc-1656	24	4	clefting	clefting	NOUN
dpc-1656	24	5	at	at	ADP
dpc-1656	24	6	the	the	DET
dpc-1656	24	7	dermoepidermal	dermoepidermal	ADJ
dpc-1656	24	8	junction	junction	NOUN
dpc-1656	24	9	and	and	CCONJ
dpc-1656	24	10	perivascular	perivascular	ADJ
dpc-1656	24	11	mononuclear	mononuclear	ADJ
dpc-1656	24	12	inflammatory	inflammatory	ADJ
dpc-1656	24	13	infiltrate	infiltrate	VERB
dpc-1656	24	14	with	with	ADP
dpc-1656	24	15	numerous	numerous	ADJ
dpc-1656	24	16	eosinophils	eosinophil	NOUN
dpc-1656	24	17	in	in	ADP
dpc-1656	24	18	the	the	DET
dpc-1656	24	19	superficial	superficial	ADJ
dpc-1656	24	20	dermis	dermis	NOUN
dpc-1656	24	21	(	(	PUNCT
dpc-1656	24	22	figure	figure	NOUN
dpc-1656	24	23	1b	1b	NUM
dpc-1656	24	24	)	)	PUNCT
dpc-1656	24	25	.	.	PUNCT
dpc-1656	25	1	direct	direct	ADJ
dpc-1656	25	2	immunofluorescence	immunofluorescence	NOUN
dpc-1656	25	3	revealed	reveal	VERB
dpc-1656	25	4	linear	linear	PROPN
dpc-1656	25	5	deposits	deposit	NOUN
dpc-1656	25	6	of	of	ADP
dpc-1656	25	7	igg	igg	PROPN
dpc-1656	25	8	and	and	CCONJ
dpc-1656	25	9	c3	c3	PROPN
dpc-1656	25	10	along	along	ADP
dpc-1656	25	11	the	the	DET
dpc-1656	25	12	basement	basement	NOUN
dpc-1656	25	13	membrane	membrane	NOUN
dpc-1656	25	14	zone	zone	NOUN
dpc-1656	25	15	.	.	PUNCT
dpc-1656	26	1	based	base	VERB
dpc-1656	26	2	on	on	ADP
dpc-1656	26	3	clinical	clinical	ADJ
dpc-1656	26	4	presentation	presentation	NOUN
dpc-1656	26	5	and	and	CCONJ
dpc-1656	26	6	histopathological	histopathological	ADJ
dpc-1656	26	7	and	and	CCONJ
dpc-1656	26	8	immunological	immunological	ADJ
dpc-1656	26	9	findings	finding	NOUN
dpc-1656	26	10	,	,	PUNCT
dpc-1656	26	11	a	a	DET
dpc-1656	26	12	diagnosis	diagnosis	NOUN
dpc-1656	26	13	of	of	ADP
dpc-1656	26	14	diffuse	diffuse	ADJ
dpc-1656	26	15	adolescent	adolescent	ADJ
dpc-1656	26	16	bp	bp	PROPN
dpc-1656	26	17	was	be	AUX
dpc-1656	26	18	made	make	VERB
dpc-1656	26	19	.	.	PUNCT
dpc-1656	27	1	the	the	DET
dpc-1656	27	2	bp	bp	PROPN
dpc-1656	27	3	disease	disease	PROPN
dpc-1656	27	4	area	area	PROPN
dpc-1656	27	5	index	index	NOUN
dpc-1656	27	6	score	score	NOUN
dpc-1656	27	7	was	be	AUX
dpc-1656	27	8	145	145	NUM
dpc-1656	27	9	.	.	PUNCT
dpc-1656	27	10	2	2	NUM
dpc-1656	27	11	research	research	NOUN
dpc-1656	27	12	letter	letter	NOUN
dpc-1656	28	1	|	|	ADV
dpc-1656	28	2	dermatol	dermatol	ADJ
dpc-1656	28	3	pract	pract	NOUN
dpc-1656	28	4	concept	concept	NOUN
dpc-1656	28	5	.	.	PUNCT
dpc-1656	29	1	2022;12(1):e2022005	2022;12(1):e2022005	NUM
dpc-1656	29	2	oral	oral	ADJ
dpc-1656	29	3	prednisolone	prednisolone	PROPN
dpc-1656	29	4	70	70	NUM
dpc-1656	29	5	mg	mg	ADV
dpc-1656	29	6	along	along	ADP
dpc-1656	29	7	with	with	ADP
dpc-1656	29	8	broad	broad	ADJ
dpc-1656	29	9	-	-	PUNCT
dpc-1656	29	10	spectrum	spectrum	NOUN
dpc-1656	29	11	antibiotic	antibiotic	ADJ
dpc-1656	29	12	cover	cover	NOUN
dpc-1656	29	13	and	and	CCONJ
dpc-1656	29	14	antihistamines	antihistamine	NOUN
dpc-1656	29	15	were	be	AUX
dpc-1656	29	16	started	start	VERB
dpc-1656	29	17	.	.	PUNCT
dpc-1656	30	1	doxycycline	doxycycline	VERB
dpc-1656	30	2	100	100	NUM
dpc-1656	30	3	mg	mg	NOUN
dpc-1656	30	4	and	and	CCONJ
dpc-1656	30	5	nicotinamide	nicotinamide	NOUN
dpc-1656	30	6	tablets	tablet	NOUN
dpc-1656	30	7	500	500	NUM
dpc-1656	30	8	mg	mg	NOUN
dpc-1656	30	9	were	be	AUX
dpc-1656	30	10	added	add	VERB
dpc-1656	30	11	as	as	ADP
dpc-1656	30	12	steroid	steroid	NOUN
dpc-1656	30	13	-	-	PUNCT
dpc-1656	30	14	sparing	spare	VERB
dpc-1656	30	15	agents	agent	NOUN
dpc-1656	30	16	,	,	PUNCT
dpc-1656	30	17	but	but	CCONJ
dpc-1656	30	18	there	there	PRON
dpc-1656	30	19	was	be	VERB
dpc-1656	30	20	a	a	DET
dpc-1656	30	21	progressive	progressive	ADJ
dpc-1656	30	22	increase	increase	NOUN
dpc-1656	30	23	in	in	ADP
dpc-1656	30	24	the	the	DET
dpc-1656	30	25	severity	severity	NOUN
dpc-1656	30	26	of	of	ADP
dpc-1656	30	27	the	the	DET
dpc-1656	30	28	eruption	eruption	NOUN
dpc-1656	30	29	.	.	PUNCT
dpc-1656	31	1	as	as	ADP
dpc-1656	31	2	a	a	DET
dpc-1656	31	3	consequence	consequence	NOUN
dpc-1656	31	4	,	,	PUNCT
dpc-1656	31	5	doxycycline	doxycycline	NOUN
dpc-1656	31	6	was	be	AUX
dpc-1656	31	7	replaced	replace	VERB
dpc-1656	31	8	by	by	ADP
dpc-1656	31	9	azathioprine	azathioprine	PROPN
dpc-1656	31	10	50	50	NUM
dpc-1656	31	11	mg	mg	NOUN
dpc-1656	31	12	twice	twice	ADV
dpc-1656	31	13	daily	daily	ADV
dpc-1656	31	14	.	.	PUNCT
dpc-1656	32	1	in	in	ADP
dpc-1656	32	2	spite	spite	NOUN
dpc-1656	32	3	of	of	ADP
dpc-1656	32	4	4	4	NUM
dpc-1656	32	5	weeks	week	NOUN
dpc-1656	32	6	of	of	ADP
dpc-1656	32	7	azathioprine	azathioprine	NOUN
dpc-1656	32	8	,	,	PUNCT
dpc-1656	32	9	there	there	PRON
dpc-1656	32	10	were	be	VERB
dpc-1656	32	11	40	40	NUM
dpc-1656	32	12	-	-	SYM
dpc-1656	32	13	50	50	NUM
dpc-1656	32	14	new	new	ADJ
dpc-1656	32	15	blisters	blister	NOUN
dpc-1656	32	16	per	per	ADP
dpc-1656	32	17	day	day	NOUN
dpc-1656	32	18	,	,	PUNCT
dpc-1656	32	19	and	and	CCONJ
dpc-1656	32	20	in	in	ADP
dpc-1656	32	21	view	view	NOUN
dpc-1656	32	22	of	of	ADP
dpc-1656	32	23	the	the	DET
dpc-1656	32	24	recalcitrance	recalcitrance	NOUN
dpc-1656	32	25	,	,	PUNCT
dpc-1656	32	26	azathioprine	azathioprine	PROPN
dpc-1656	32	27	was	be	AUX
dpc-1656	32	28	discontinued	discontinue	VERB
dpc-1656	32	29	and	and	CCONJ
dpc-1656	32	30	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	32	31	100	100	NUM
dpc-1656	32	32	mg	mg	PROPN
dpc-1656	32	33	was	be	AUX
dpc-1656	32	34	added	add	VERB
dpc-1656	32	35	.	.	PUNCT
dpc-1656	33	1	after	after	ADP
dpc-1656	33	2	2	2	NUM
dpc-1656	33	3	weeks	week	NOUN
dpc-1656	33	4	,	,	PUNCT
dpc-1656	33	5	the	the	DET
dpc-1656	33	6	number	number	NOUN
dpc-1656	33	7	of	of	ADP
dpc-1656	33	8	new	new	ADJ
dpc-1656	33	9	lesions	lesion	NOUN
dpc-1656	33	10	gradually	gradually	ADV
dpc-1656	33	11	decreased	decrease	VERB
dpc-1656	33	12	and	and	CCONJ
dpc-1656	33	13	old	old	ADJ
dpc-1656	33	14	lesions	lesion	NOUN
dpc-1656	33	15	started	start	VERB
dpc-1656	33	16	to	to	PART
dpc-1656	33	17	heal	heal	VERB
dpc-1656	33	18	.	.	PUNCT
dpc-1656	34	1	the	the	DET
dpc-1656	34	2	patient	patient	NOUN
dpc-1656	34	3	was	be	AUX
dpc-1656	34	4	discharged	discharge	VERB
dpc-1656	34	5	on	on	ADP
dpc-1656	34	6	prednisolone	prednisolone	PROPN
dpc-1656	34	7	50	50	NUM
dpc-1656	34	8	mg	mg	NOUN
dpc-1656	34	9	and	and	CCONJ
dpc-1656	34	10	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	34	11	100	100	NUM
dpc-1656	34	12	mg	mg	PROPN
dpc-1656	34	13	.	.	PUNCT
dpc-1656	35	1	two	two	NUM
dpc-1656	35	2	weeks	week	NOUN
dpc-1656	35	3	later	later	ADV
dpc-1656	35	4	the	the	DET
dpc-1656	35	5	dose	dose	NOUN
dpc-1656	35	6	of	of	ADP
dpc-1656	35	7	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	35	8	and	and	CCONJ
dpc-1656	35	9	prednisolone	prednisolone	PROPN
dpc-1656	35	10	was	be	AUX
dpc-1656	35	11	tapered	taper	VERB
dpc-1656	35	12	to	to	ADP
dpc-1656	35	13	50	50	NUM
dpc-1656	35	14	mg	mg	NOUN
dpc-1656	35	15	and	and	CCONJ
dpc-1656	35	16	40	40	NUM
dpc-1656	35	17	mg	mg	NUM
dpc-1656	35	18	,	,	PUNCT
dpc-1656	35	19	respectively	respectively	ADV
dpc-1656	35	20	.	.	PUNCT
dpc-1656	36	1	during	during	ADP
dpc-1656	36	2	treatment	treatment	NOUN
dpc-1656	36	3	patient	patient	NOUN
dpc-1656	36	4	routine	routine	ADJ
dpc-1656	36	5	hematological	hematological	ADJ
dpc-1656	36	6	investigations	investigation	NOUN
dpc-1656	36	7	and	and	CCONJ
dpc-1656	36	8	urineanalysis	urineanalysis	NOUN
dpc-1656	36	9	were	be	AUX
dpc-1656	36	10	normal	normal	ADJ
dpc-1656	36	11	.	.	PUNCT
dpc-1656	37	1	over	over	ADP
dpc-1656	37	2	the	the	DET
dpc-1656	37	3	next	next	ADJ
dpc-1656	37	4	4	4	NUM
dpc-1656	37	5	weeks	week	NOUN
dpc-1656	37	6	,	,	PUNCT
dpc-1656	37	7	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	37	8	was	be	AUX
dpc-1656	37	9	stopped	stop	VERB
dpc-1656	37	10	.	.	PUNCT
dpc-1656	38	1	azathioprine	azathioprine	PROPN
dpc-1656	38	2	was	be	AUX
dpc-1656	38	3	restarted	restart	VERB
dpc-1656	38	4	at	at	ADP
dpc-1656	38	5	a	a	DET
dpc-1656	38	6	dose	dose	NOUN
dpc-1656	38	7	of	of	ADP
dpc-1656	38	8	25	25	NUM
dpc-1656	38	9	mg	mg	NOUN
dpc-1656	38	10	and	and	CCONJ
dpc-1656	38	11	gradually	gradually	ADV
dpc-1656	38	12	increased	increase	VERB
dpc-1656	38	13	.	.	PUNCT
dpc-1656	39	1	currently	currently	ADV
dpc-1656	39	2	the	the	DET
dpc-1656	39	3	patient	patient	NOUN
dpc-1656	39	4	is	be	AUX
dpc-1656	39	5	undergoing	undergo	VERB
dpc-1656	39	6	oral	oral	ADJ
dpc-1656	39	7	prednisolone	prednisolone	PROPN
dpc-1656	39	8	15	15	NUM
dpc-1656	39	9	mg	mg	NOUN
dpc-1656	39	10	and	and	CCONJ
dpc-1656	39	11	azathioprine	azathioprine	VERB
dpc-1656	39	12	50	50	NUM
dpc-1656	39	13	mg	mg	NOUN
dpc-1656	39	14	with	with	ADP
dpc-1656	39	15	a	a	DET
dpc-1656	39	16	good	good	ADJ
dpc-1656	39	17	control	control	NOUN
dpc-1656	39	18	of	of	ADP
dpc-1656	39	19	her	her	PRON
dpc-1656	39	20	disease	disease	NOUN
dpc-1656	39	21	without	without	ADP
dpc-1656	39	22	any	any	DET
dpc-1656	39	23	side	side	NOUN
dpc-1656	39	24	-	-	PUNCT
dpc-1656	39	25	effects	effect	NOUN
dpc-1656	39	26	.	.	PUNCT
dpc-1656	40	1	the	the	DET
dpc-1656	40	2	patient	patient	NOUN
dpc-1656	40	3	is	be	AUX
dpc-1656	40	4	on	on	ADP
dpc-1656	40	5	regular	regular	ADJ
dpc-1656	40	6	follow	follow	NOUN
dpc-1656	40	7	-	-	PUNCT
dpc-1656	40	8	up	up	NOUN
dpc-1656	40	9	at	at	ADP
dpc-1656	40	10	a	a	DET
dpc-1656	40	11	4to	4to	ADJ
dpc-1656	40	12	6	6	NUM
dpc-1656	40	13	-	-	PUNCT
dpc-1656	40	14	week	week	NOUN
dpc-1656	40	15	intervals	interval	NOUN
dpc-1656	40	16	with	with	ADP
dpc-1656	40	17	no	no	DET
dpc-1656	40	18	relapse	relapse	NOUN
dpc-1656	40	19	of	of	ADP
dpc-1656	40	20	bullous	bullous	ADJ
dpc-1656	40	21	lesions	lesion	NOUN
dpc-1656	40	22	but	but	CCONJ
dpc-1656	40	23	with	with	ADP
dpc-1656	40	24	residual	residual	ADJ
dpc-1656	40	25	pigmentary	pigmentary	ADJ
dpc-1656	40	26	changes	change	NOUN
dpc-1656	40	27	(	(	PUNCT
dpc-1656	40	28	figure	figure	NOUN
dpc-1656	40	29	2	2	NUM
dpc-1656	40	30	)	)	PUNCT
dpc-1656	40	31	.	.	PUNCT
dpc-1656	41	1	informed	informed	ADJ
dpc-1656	41	2	consent	consent	NOUN
dpc-1656	41	3	has	have	AUX
dpc-1656	41	4	been	be	AUX
dpc-1656	41	5	taken	take	VERB
dpc-1656	41	6	from	from	ADP
dpc-1656	41	7	patient	patient	ADJ
dpc-1656	41	8	guardian	guardian	NOUN
dpc-1656	41	9	(	(	PUNCT
dpc-1656	41	10	patient	patient	NOUN
dpc-1656	41	11	is	be	AUX
dpc-1656	41	12	minor	minor	ADJ
dpc-1656	41	13	)	)	PUNCT
dpc-1656	41	14	for	for	ADP
dpc-1656	41	15	the	the	DET
dpc-1656	41	16	nature	nature	NOUN
dpc-1656	41	17	and	and	CCONJ
dpc-1656	41	18	side	side	NOUN
dpc-1656	41	19	-	-	PUNCT
dpc-1656	41	20	effects	effect	NOUN
dpc-1656	41	21	of	of	ADP
dpc-1656	41	22	drug	drug	NOUN
dpc-1656	41	23	(	(	PUNCT
dpc-1656	41	24	cyclophosphamide	cyclophosphamide	NOUN
dpc-1656	41	25	)	)	PUNCT
dpc-1656	41	26	.	.	PUNCT
dpc-1656	42	1	conclusions	conclusion	NOUN
dpc-1656	42	2	bp	bp	PROPN
dpc-1656	42	3	is	be	AUX
dpc-1656	42	4	the	the	DET
dpc-1656	42	5	commonest	common	ADJ
dpc-1656	42	6	immunobullous	immunobullous	ADJ
dpc-1656	42	7	disorder	disorder	NOUN
dpc-1656	42	8	worldwide	worldwide	ADV
dpc-1656	42	9	,	,	PUNCT
dpc-1656	42	10	but	but	CCONJ
dpc-1656	42	11	it	it	PRON
dpc-1656	42	12	is	be	AUX
dpc-1656	42	13	rare	rare	ADJ
dpc-1656	42	14	in	in	ADP
dpc-1656	42	15	childhood	childhood	NOUN
dpc-1656	42	16	(	(	PUNCT
dpc-1656	42	17	100	100	NUM
dpc-1656	42	18	cases	case	NOUN
dpc-1656	42	19	)	)	PUNCT
dpc-1656	42	20	and	and	CCONJ
dpc-1656	42	21	extremely	extremely	ADV
dpc-1656	42	22	uncommon	uncommon	ADJ
dpc-1656	42	23	in	in	ADP
dpc-1656	42	24	adolescence	adolescence	NOUN
dpc-1656	42	25	(	(	PUNCT
dpc-1656	42	26	14	14	NUM
dpc-1656	42	27	cases	case	NOUN
dpc-1656	42	28	)	)	PUNCT
dpc-1656	43	1	[	[	X
dpc-1656	43	2	1	1	NUM
dpc-1656	43	3	]	]	PUNCT
dpc-1656	43	4	.	.	PUNCT
dpc-1656	44	1	childhood	childhood	PROPN
dpc-1656	44	2	bp	bp	PROPN
dpc-1656	44	3	is	be	AUX
dpc-1656	44	4	diagnosed	diagnose	VERB
dpc-1656	44	5	according	accord	VERB
dpc-1656	44	6	to	to	ADP
dpc-1656	44	7	the	the	DET
dpc-1656	44	8	criteria	criterion	NOUN
dpc-1656	44	9	of	of	ADP
dpc-1656	44	10	nemeth	nemeth	PROPN
dpc-1656	44	11	,	,	PUNCT
dpc-1656	44	12	and	and	CCONJ
dpc-1656	44	13	our	our	PRON
dpc-1656	44	14	case	case	NOUN
dpc-1656	44	15	satisfied	satisfy	VERB
dpc-1656	44	16	these	these	DET
dpc-1656	44	17	criteria	criterion	NOUN
dpc-1656	44	18	.	.	PUNCT
dpc-1656	45	1	bp	bp	PROPN
dpc-1656	45	2	is	be	AUX
dpc-1656	45	3	generally	generally	ADV
dpc-1656	45	4	more	more	ADV
dpc-1656	45	5	responsive	responsive	ADJ
dpc-1656	45	6	to	to	ADP
dpc-1656	45	7	treatment	treatment	NOUN
dpc-1656	45	8	than	than	ADP
dpc-1656	45	9	pemphigus	pemphigus	NOUN
dpc-1656	45	10	vulgaris	vulgaris	NOUN
dpc-1656	45	11	,	,	PUNCT
dpc-1656	45	12	but	but	CCONJ
dpc-1656	45	13	there	there	PRON
dpc-1656	45	14	are	be	VERB
dpc-1656	45	15	refractory	refractory	NOUN
dpc-1656	45	16	cases	case	NOUN
dpc-1656	45	17	in	in	ADP
dpc-1656	45	18	figure	figure	NOUN
dpc-1656	45	19	1	1	NUM
dpc-1656	45	20	.	.	PUNCT
dpc-1656	46	1	(	(	PUNCT
dpc-1656	46	2	a	a	X
dpc-1656	46	3	)	)	PUNCT
dpc-1656	46	4	multiple	multiple	ADJ
dpc-1656	46	5	tense	tense	ADJ
dpc-1656	46	6	vesicles	vesicle	NOUN
dpc-1656	46	7	and	and	CCONJ
dpc-1656	46	8	bullae	bullae	NOUN
dpc-1656	46	9	over	over	ADP
dpc-1656	46	10	an	an	DET
dpc-1656	46	11	erythematous	erythematous	ADJ
dpc-1656	46	12	base	base	NOUN
dpc-1656	46	13	.	.	PUNCT
dpc-1656	47	1	(	(	PUNCT
dpc-1656	47	2	b)subepidermal	b)subepidermal	ADJ
dpc-1656	47	3	blister	blister	NOUN
dpc-1656	47	4	containing	contain	VERB
dpc-1656	47	5	fibrin	fibrin	NOUN
dpc-1656	47	6	and	and	CCONJ
dpc-1656	47	7	eosinophils	eosinophil	NOUN
dpc-1656	47	8	peri	peri	NOUN
dpc-1656	47	9	adnexal	adnexal	VERB
dpc-1656	47	10	infiltrate	infiltrate	ADV
dpc-1656	47	11	of	of	ADP
dpc-1656	47	12	eosinophils	eosinophil	NOUN
dpc-1656	47	13	in	in	ADP
dpc-1656	47	14	the	the	DET
dpc-1656	47	15	dermis	dermis	NOUN
dpc-1656	47	16	(	(	PUNCT
dpc-1656	47	17	hematoxylin	hematoxylin	NOUN
dpc-1656	47	18	and	and	CCONJ
dpc-1656	47	19	eosin	eosin	NOUN
dpc-1656	47	20	stain	stain	NOUN
dpc-1656	47	21	,	,	PUNCT
dpc-1656	47	22	×40	×40	PROPN
dpc-1656	47	23	)	)	PUNCT
dpc-1656	47	24	.	.	PUNCT
dpc-1656	48	1	figure	figure	NOUN
dpc-1656	48	2	2	2	NUM
dpc-1656	48	3	.	.	PUNCT
dpc-1656	48	4	healed	heal	VERB
dpc-1656	48	5	lesions	lesion	NOUN
dpc-1656	48	6	with	with	ADP
dpc-1656	48	7	residual	residual	ADJ
dpc-1656	48	8	pigmentary	pigmentary	ADJ
dpc-1656	48	9	changes	change	NOUN
dpc-1656	48	10	.	.	PUNCT
dpc-1656	49	1	which	which	DET
dpc-1656	49	2	treatment	treatment	NOUN
dpc-1656	49	3	resistance	resistance	NOUN
dpc-1656	49	4	occurs	occur	VERB
dpc-1656	49	5	.	.	PUNCT
dpc-1656	50	1	childhood	childhood	PROPN
dpc-1656	50	2	bp	bp	PROPN
dpc-1656	50	3	usually	usually	ADV
dpc-1656	50	4	has	have	VERB
dpc-1656	50	5	a	a	DET
dpc-1656	50	6	good	good	ADJ
dpc-1656	50	7	prognosis	prognosis	NOUN
dpc-1656	50	8	,	,	PUNCT
dpc-1656	50	9	although	although	SCONJ
dpc-1656	50	10	,	,	PUNCT
dpc-1656	50	11	in	in	ADP
dpc-1656	50	12	some	some	DET
dpc-1656	50	13	cases	case	NOUN
dpc-1656	50	14	the	the	DET
dpc-1656	50	15	course	course	NOUN
dpc-1656	50	16	is	be	AUX
dpc-1656	50	17	less	less	ADV
dpc-1656	50	18	benign	benign	ADJ
dpc-1656	50	19	[	[	PUNCT
dpc-1656	50	20	2	2	NUM
dpc-1656	50	21	]	]	PUNCT
dpc-1656	50	22	.	.	PUNCT
dpc-1656	51	1	our	our	PRON
dpc-1656	51	2	case	case	NOUN
dpc-1656	51	3	had	have	VERB
dpc-1656	51	4	generalized	generalize	VERB
dpc-1656	51	5	bp	bp	PROPN
dpc-1656	51	6	,	,	PUNCT
dpc-1656	51	7	poor	poor	ADJ
dpc-1656	51	8	response	response	NOUN
dpc-1656	51	9	to	to	ADP
dpc-1656	51	10	high	high	ADJ
dpc-1656	51	11	doses	dose	NOUN
dpc-1656	51	12	of	of	ADP
dpc-1656	51	13	steroid	steroid	NOUN
dpc-1656	51	14	,	,	PUNCT
dpc-1656	51	15	anti	anti	ADJ
dpc-1656	51	16	-	-	ADJ
dpc-1656	51	17	inflammatory	inflammatory	ADJ
dpc-1656	51	18	,	,	PUNCT
dpc-1656	51	19	antibiotics	antibiotic	NOUN
dpc-1656	51	20	and	and	CCONJ
dpc-1656	51	21	azathioprine	azathioprine	NOUN
dpc-1656	51	22	.	.	PUNCT
dpc-1656	52	1	non	non	ADJ
dpc-1656	52	2	-	-	NOUN
dpc-1656	52	3	availability	availability	NOUN
dpc-1656	52	4	of	of	ADP
dpc-1656	52	5	biologics	biologic	NOUN
dpc-1656	52	6	at	at	ADP
dpc-1656	52	7	our	our	PRON
dpc-1656	52	8	center	center	NOUN
dpc-1656	52	9	and	and	CCONJ
dpc-1656	52	10	economic	economic	ADJ
dpc-1656	52	11	constraints	constraint	NOUN
dpc-1656	52	12	resulted	result	VERB
dpc-1656	52	13	in	in	ADP
dpc-1656	52	14	the	the	DET
dpc-1656	52	15	use	use	NOUN
dpc-1656	52	16	of	of	ADP
dpc-1656	52	17	cyclophosphamide	cyclophosphamide	NOUN
dpc-1656	52	18	that	that	PRON
dpc-1656	52	19	was	be	AUX
dpc-1656	52	20	administered	administer	VERB
dpc-1656	52	21	as	as	ADP
dpc-1656	52	22	a	a	DET
dpc-1656	52	23	“	"	PUNCT
dpc-1656	52	24	rescue	rescue	NOUN
dpc-1656	52	25	therapy	therapy	NOUN
dpc-1656	52	26	”	"	PUNCT
dpc-1656	52	27	in	in	ADP
dpc-1656	52	28	view	view	NOUN
dpc-1656	52	29	of	of	ADP
dpc-1656	52	30	its	its	PRON
dpc-1656	52	31	side	side	ADJ
dpc-1656	52	32	effect	effect	NOUN
dpc-1656	52	33	profile	profile	NOUN
dpc-1656	52	34	.	.	PUNCT
dpc-1656	53	1	our	our	PRON
dpc-1656	53	2	case	case	NOUN
dpc-1656	53	3	exemplified	exemplify	VERB
dpc-1656	53	4	the	the	DET
dpc-1656	53	5	role	role	NOUN
dpc-1656	53	6	of	of	ADP
dpc-1656	53	7	cyclophosphamide	cyclophosphamide	NOUN
dpc-1656	53	8	as	as	ADP
dpc-1656	53	9	a	a	DET
dpc-1656	53	10	short	short	ADJ
dpc-1656	53	11	-	-	PUNCT
dpc-1656	53	12	term	term	NOUN
dpc-1656	53	13	bridge	bridge	NOUN
dpc-1656	53	14	therapy	therapy	NOUN
dpc-1656	53	15	,	,	PUNCT
dpc-1656	53	16	after	after	ADP
dpc-1656	53	17	which	which	PRON
dpc-1656	53	18	the	the	DET
dpc-1656	53	19	patient	patient	NOUN
dpc-1656	53	20	was	be	AUX
dpc-1656	53	21	adequately	adequately	ADV
dpc-1656	53	22	controlled	control	VERB
dpc-1656	53	23	on	on	ADP
dpc-1656	53	24	azathioprine	azathioprine	NOUN
dpc-1656	53	25	.	.	PUNCT
dpc-1656	54	1	in	in	ADP
dpc-1656	54	2	a	a	DET
dpc-1656	54	3	severe	severe	ADJ
dpc-1656	54	4	and	and	CCONJ
dpc-1656	54	5	recalcitrant	recalcitrant	ADJ
dpc-1656	54	6	case	case	NOUN
dpc-1656	54	7	,	,	PUNCT
dpc-1656	54	8	such	such	ADJ
dpc-1656	54	9	as	as	ADP
dpc-1656	54	10	this	this	DET
dpc-1656	54	11	one	one	NOUN
dpc-1656	54	12	,	,	PUNCT
dpc-1656	54	13	cyclophosphamide	cyclophosphamide	PROPN
dpc-1656	54	14	can	can	AUX
dpc-1656	54	15	be	be	AUX
dpc-1656	54	16	used	use	VERB
dpc-1656	54	17	to	to	PART
dpc-1656	54	18	bring	bring	VERB
dpc-1656	54	19	the	the	DET
dpc-1656	54	20	disease	disease	NOUN
dpc-1656	54	21	under	under	ADP
dpc-1656	54	22	control	control	NOUN
dpc-1656	54	23	.	.	PUNCT
dpc-1656	55	1	informed	informed	ADJ
dpc-1656	55	2	consent	consent	NOUN
dpc-1656	55	3	:	:	PUNCT
dpc-1656	55	4	written	write	VERB
dpc-1656	55	5	informed	informed	ADJ
dpc-1656	55	6	consent	consent	NOUN
dpc-1656	55	7	for	for	ADP
dpc-1656	55	8	publication	publication	NOUN
dpc-1656	55	9	of	of	ADP
dpc-1656	55	10	clinical	clinical	ADJ
dpc-1656	55	11	details	detail	NOUN
dpc-1656	55	12	and	and	CCONJ
dpc-1656	55	13	clinical	clinical	ADJ
dpc-1656	55	14	images	image	NOUN
dpc-1656	55	15	was	be	AUX
dpc-1656	55	16	obtained	obtain	VERB
dpc-1656	55	17	from	from	ADP
dpc-1656	55	18	the	the	DET
dpc-1656	55	19	patient	patient	NOUN
dpc-1656	55	20	.	.	PUNCT
dpc-1656	56	1	references	reference	NOUN
dpc-1656	56	2	1	1	NUM
dpc-1656	56	3	.	.	PUNCT
dpc-1656	56	4	patsatsi	patsatsi	PROPN
dpc-1656	57	1	a	a	PRON
dpc-1656	57	2	,	,	PUNCT
dpc-1656	57	3	kyriakou	kyriakou	PROPN
dpc-1656	57	4	a	a	X
dpc-1656	57	5	,	,	PUNCT
dpc-1656	57	6	werth	werth	PROPN
dpc-1656	57	7	vp	vp	PROPN
dpc-1656	57	8	.	.	PUNCT
dpc-1656	57	9	bullous	bullous	ADJ
dpc-1656	57	10	pemphigoid	pemphigoid	NOUN
dpc-1656	57	11	in	in	ADP
dpc-1656	57	12	adolescence	adolescence	NOUN
dpc-1656	57	13	.	.	PUNCT
dpc-1656	57	14	 	 	SPACE
dpc-1656	58	1	pediatr	pediatr	ADJ
dpc-1656	58	2	dermatol	dermatol	NOUN
dpc-1656	58	3	.	.	PUNCT
dpc-1656	59	1	2019;36(2):184	2019;36(2):184	NUM
dpc-1656	59	2	-	-	SYM
dpc-1656	59	3	188	188	NUM
dpc-1656	59	4	.	.	PUNCT
dpc-1656	60	1	doi	doi	NOUN
dpc-1656	60	2	:	:	PUNCT
dpc-1656	60	3	10.1111/	10.1111/	NUM
dpc-1656	60	4	pde.13717	pde.13717	PROPN
dpc-1656	60	5	.	.	PUNCT
dpc-1656	61	1	pmid	pmid	NOUN
dpc-1656	61	2	:	:	PUNCT
dpc-1656	61	3	30569520	30569520	NUM
dpc-1656	61	4	.	.	PUNCT
dpc-1656	62	1	2	2	NUM
dpc-1656	62	2	.	.	X
dpc-1656	62	3	nemeth	nemeth	PROPN
dpc-1656	62	4	aj	aj	PROPN
dpc-1656	62	5	,	,	PUNCT
dpc-1656	62	6	klein	klein	PROPN
dpc-1656	62	7	ad	ad	PROPN
dpc-1656	62	8	,	,	PUNCT
dpc-1656	62	9	gould	gould	PROPN
dpc-1656	62	10	ew	ew	PROPN
dpc-1656	62	11	,	,	PUNCT
dpc-1656	62	12	schachner	schachner	PROPN
dpc-1656	62	13	la	la	PROPN
dpc-1656	62	14	.	.	PUNCT
dpc-1656	63	1	childhood	childhood	PROPN
dpc-1656	63	2	bullous	bullous	ADJ
dpc-1656	63	3	pemphigoid	pemphigoid	ADV
dpc-1656	63	4	:	:	PUNCT
dpc-1656	63	5	 	 	SPACE
dpc-1656	63	6	clinical	clinical	ADJ
dpc-1656	63	7	and	and	CCONJ
dpc-1656	63	8	immunologic	immunologic	ADJ
dpc-1656	63	9	features	feature	NOUN
dpc-1656	63	10	,	,	PUNCT
dpc-1656	63	11	treatment	treatment	NOUN
dpc-1656	63	12	,	,	PUNCT
dpc-1656	63	13	and	and	CCONJ
dpc-1656	63	14	prognosis	prognosis	NOUN
dpc-1656	63	15	.	.	PUNCT
dpc-1656	63	16	  	  	SPACE
dpc-1656	63	17	arch	arch	ADJ
dpc-1656	63	18	dermatol	dermatol	NOUN
dpc-1656	63	19	.	.	PUNCT
dpc-1656	63	20	  	  	SPACE
dpc-1656	63	21	1991;127(3):378–386	1991;127(3):378–386	NUM
dpc-1656	63	22	.	.	PUNCT
dpc-1656	64	1	doi:10.1001	doi:10.1001	PROPN
dpc-1656	64	2	/	/	SYM
dpc-1656	64	3	archderm.1991.01680030098014	archderm.1991.01680030098014	PROPN
dpc-1656	64	4	.	.	PUNCT
dpc-1656	65	1	pmid	pmid	NOUN
dpc-1656	65	2	:	:	PUNCT
dpc-1656	65	3	1998369	1998369	NUM
dpc-1656	65	4	.	.	PUNCT